Skip to main content

#154462

16E6/E7-HSK cell line

Cat. #154462

16E6/E7-HSK cell line

Cat. #: 154462

Sub-type: Primary

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Skin

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Aloysius Klingelhutz

Institute: The University of Iowa

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: 16E6/E7-HSK cell line
  • Research fields: Cancer
  • Tool sub type: Primary
  • Parental cell: Keratinocytes isolated from punch biopsies of the skin from the buttocks
  • Organism: Human
  • Tissue: Skin
  • Disease: Cancer
  • Growth properties: Upregulation of telomerase and greatly extended lifespan (greater than 5 times the lifespan of untransduced keratinocytes) with no apparent crisis or slow down in growth. Despite upregulation of telomerase, E6/E7 transduced keratinocytes exhibited significant telomere shortening with passaging in culture
  • Conditional: No
  • Description: Expresses skin cell markers; proinflammatory. Tissue is adult skin cells.
  • Production details: Cells were transduced with HPV-16 E6/E7 LXSN replication defective retrovirus and selected in G418
  • Biosafety level: 1

Target Details

  • Target: Used as an immortal adult human skin keratinocyte line for pathogenesis and inflammation studies

Handling

  • Format: Frozen
  • Growth medium: G418 selection.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

References

  • Gourronc et al. 2010. Exp Dermatol. 19(3):279-88. PMID: 19558498.
  • Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA compon

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.